Commit To Purchase BioMarin Pharmaceutical At $70, Earn 8.1% Using Options
March 15, 2017 at 11:49 AM EDT
Investors eyeing a purchase of BioMarin Pharmaceutical Inc. (BMRN) stock, but cautious about paying the going market price of $91.32/share, might benefit from considering selling puts among the alternative strategies at their disposal..